Finance

Lists
NUVB:NYSE
Nuvation Bio Inc
US$ ४.७५
+१.५०%
(+०.०७०) 1D
US$ ४.७०
-१.०५% (-०.०५०)
After hours
Closed: अक्टोबर १५, १६:००:०७ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
US$ ४.७४
High
US$ ४.८६
Low
US$ ४.६७
Mkt. cap
१.६७ अरब
Avg. vol.
५४.१३ लाख
Volume
१४७.००
52-wk high
US$ ९.७५
52-wk low
US$ ३.३६
EPS
-US$ ०.४४
Beta
१.६१
Shares outstanding
३५.११ करोड
No. of employees
३०५
Open
US$ ४.७४
High
US$ ४.८६
Low
US$ ४.६७
Mkt. cap
१.६७ अरब
Avg. vol.
५४.१३ लाख
Volume
१४७.००
52-wk high
US$ ९.७५
52-wk low
US$ ३.३६
EPS
-US$ ०.४४
Beta
१.६१
Shares outstanding
३५.११ करोड
No. of employees
३०५
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
१७ घण्टा पहिले
Top 3 Penny Stocks To Watch In October 2026
About Nuvation Bio Inc
CEODavid Hung
Employees३०५
Founded२०१८
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current US$ ४.७५
US$ २१.०० (+३४२.११%)
Average
US$ १४.५७ (+२०६.७४%)
Lowest
US$ ११.०० (+१३१.५८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
US$ २०.००
+३२१.१%
10/12/2026
Geoff Meacham
Citi
Buy
Initiated
US$ १२.००
+१५२.६%
10/01/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
US$ ११.००
+१३१.६%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
US$ १२.००
+१५२.६%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$ १४.००
+१९४.७%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ २१.००
+३४२.१%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
US$ १२.००
+१५२.६%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$ १२.००
+१५२.६%
04/06/2026
Michael Yee
UBS
Hold
Maintained
US$ ७.००
+४७.४%
03/03/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-US$ ०.१५ / -US$ ०.१२
-२५.१५%miss
Revenue / Est. (USD)
३.१७ करोड / २.८७ करोड
+१०.४२%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.३१ करोड
४.१९ करोड
८.३२ करोड
३.१७ करोड
Cost of goods sold
३३.४९ लाख
१२.७९ लाख
५९.९१ लाख
९४.७१ लाख
Cost of revenue
३३.४९ लाख
१२.७९ लाख
५९.९१ लाख
९४.७१ लाख
Research and development expenses
२.८८ करोड
३.४३ करोड
३.५० करोड
३.०७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.७४ करोड
४.०३ करोड
३.८३ करोड
४.२६ करोड
Operating expense
६.६२ करोड
७.४६ करोड
७.३४ करोड
७.३३ करोड
Total operating expenses
६.९६ करोड
७.५९ करोड
७.९३ करोड
८.२७ करोड
Operating income
-५.६४ करोड
-३.४० करोड
३८.८१ लाख
-५.१० करोड
Other non operating income
११.३९ लाख
-११.७८ लाख
३१.०८ लाख
-१.७९ लाख
EBT including unusual items
-५.५८ करोड
-३.६६ करोड
५३.९७ लाख
-६.२८ करोड
EBT excluding unusual items
-५.५८ करोड
-३.६६ करोड
५३.८९ लाख
-५.३४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-५.५८ करोड
-३.६६ करोड
५३.९७ लाख
-६.२८ करोड
Net profit margin
-४२५.२४%
-८७.४०%
६.४८%
-१९८.३१%
Earnings per share
-०.१४
-०.०९
०.०४
-०.१५
Interest and investment income
६०.३३ लाख
५२.९६ लाख
५१.०८ लाख
४५.९६ लाख
Interest expense
-६५.३४ लाख
-६६.७३ लाख
-६७.०८ लाख
-६७.५९ लाख
Net interest expenses
-५.०१ लाख
-१३.७७ लाख
-१६.०० लाख
-२१.६३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-५.५९ करोड
-३.३५ करोड
४४.१७ लाख
-५.०५ करोड
Gain or loss from assets sale
-४.०० हजार
३.०० हजार
-
-१.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू